Literature DB >> 17242139

First linezolid-resistant clinical isolates of Mycobacterium tuberculosis.

Elvira Richter1, Sabine Rüsch-Gerdes, Doris Hillemann.   

Abstract

Linezolid resistance was found in 4 (1.9%) of 210 multidrug-resistant Mycobacterium tuberculosis strains. The MICs of linezolid were 4 microg/ml (one strain) and 8 microg/ml (three strains). Since no mutations were detected in potential target genes, the mechanism of resistance remains unclear.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17242139      PMCID： PMC1855508          DOI： 10.1128/AAC.01113-06

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  12 in total

1.  Pharmacokinetics and tissue penetration of linezolid following multiple oral doses.

Authors:  T Gee; R Ellis; G Marshall; J Andrews; J Ashby; R Wise
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

2.  Novel mechanism of resistance to oxazolidinones, macrolides, and chloramphenicol in ribosomal protein L4 of the pneumococcus.

Authors:  Nicole Wolter; Anthony M Smith; David J Farrell; William Schaffner; Matthew Moore; Cynthia G Whitney; James H Jorgensen; Keith P Klugman
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

3.  Rapid detection of Mycobacterium tuberculosis Beijing genotype strains by real-time PCR.

Authors:  Doris Hillemann; Rob Warren; Tanja Kubica; Sabine Rüsch-Gerdes; Stefan Niemann
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

4.  Multicenter laboratory validation of the BACTEC MGIT 960 technique for testing susceptibilities of Mycobacterium tuberculosis to classical second-line drugs and newer antimicrobials.

Authors:  Sabine Rüsch-Gerdes; Gaby E Pfyffer; Manuel Casal; Maureen Chadwick; Salman Siddiqi
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

5.  Mechanism of action of the oxazolidinone antibacterial agents.

Authors:  D Shinabarger
Journal:  Expert Opin Investig Drugs       Date:  1999-08       Impact factor: 6.206

6.  mmpL7 gene of Mycobacterium tuberculosis is responsible for isoniazid efflux in Mycobacterium smegmatis.

Authors:  Maria R Pasca; Paola Guglierame; Edda De Rossi; Francesca Zara; Giovanna Riccardi
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

7.  Ribosomal and non-ribosomal resistance to oxazolidinones: species-specific idiosyncrasy of ribosomal alterations.

Authors:  P Sander; L Belova; Y G Kidan; P Pfister; A S Mankin; E C Böttger
Journal:  Mol Microbiol       Date:  2002-12       Impact factor: 3.501

Review 8.  Oxazolidinones: a new class of antibacterials.

Authors:  G E Zurenko; J K Gibson; D L Shinabarger; P A Aristoff; C W Ford; W G Tarpley
Journal:  Curr Opin Pharmacol       Date:  2001-10       Impact factor: 5.547

9.  The oxazolidinone eperezolid binds to the 50S ribosomal subunit and competes with binding of chloramphenicol and lincomycin.

Authors:  A H Lin; R W Murray; T J Vidmar; K R Marotti
Journal:  Antimicrob Agents Chemother       Date:  1997-10       Impact factor: 5.191

Review 10.  Oxazolidinones: activity, mode of action, and mechanism of resistance.

Authors:  Bülent Bozdogan; Peter C Appelbaum
Journal:  Int J Antimicrob Agents       Date:  2004-02       Impact factor: 5.283
View more
  35 in total

Review 1.  Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.

Authors:  Barbara A Brown-Elliott; Kevin A Nash; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

2.  In vitro-selected linezolid-resistant Mycobacterium tuberculosis mutants.

Authors:  Doris Hillemann; Sabine Rüsch-Gerdes; Elvira Richter
Journal:  Antimicrob Agents Chemother       Date:  2007-12-10       Impact factor: 5.191

3.  In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis complex isolated in Taiwan over 10 years.

Authors:  Tsi-Shu Huang; Yung-Ching Liu; Cheng-Len Sy; Yao-Shen Chen; Hui-Zin Tu; Bao-Chen Chen
Journal:  Antimicrob Agents Chemother       Date:  2008-04-07       Impact factor: 5.191

4.  rplC T460C identified as a dominant mutation in linezolid-resistant Mycobacterium tuberculosis strains.

Authors:  Patrick Beckert; Doris Hillemann; Thomas A Kohl; Jörn Kalinowski; Elvira Richter; Stefan Niemann; Silke Feuerriegel
Journal:  Antimicrob Agents Chemother       Date:  2012-02-27       Impact factor: 5.191

Review 5.  Cure of tuberculosis using nanotechnology: An overview.

Authors:  Rout George Kerry; Sushanto Gouda; Bikram Sil; Gitishree Das; Han-Seung Shin; Gajanan Ghodake; Jayanta Kumar Patra
Journal:  J Microbiol       Date:  2018-05-02       Impact factor: 3.422

Review 6.  Tuberculosis diagnostics in 2015: landscape, priorities, needs, and prospects.

Authors:  Madhukar Pai; Marco Schito
Journal:  J Infect Dis       Date:  2015-04-01       Impact factor: 5.226

7.  Role of the Cys154Arg Substitution in Ribosomal Protein L3 in Oxazolidinone Resistance in Mycobacterium tuberculosis.

Authors:  Gaëlle Guiewi Makafe; Yuanyuan Cao; Yaoju Tan; Mugweru Julius; Zhiyong Liu; Changwei Wang; Moses M Njire; Xingshan Cai; Tianzhou Liu; Bangxing Wang; Wei Pang; Shouyong Tan; Buchang Zhang; Wing Wai Yew; Gyanu Lamichhane; Jintao Guo; Tianyu Zhang
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

8.  Antimicrobial efflux pumps and Mycobacterium tuberculosis drug tolerance: evolutionary considerations.

Authors:  John D Szumowski; Kristin N Adams; Paul H Edelstein; Lalita Ramakrishnan
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

9.  Linezolid for treatment of chronic extensively drug-resistant tuberculosis.

Authors:  Myungsun Lee; Jongseok Lee; Matthew W Carroll; Hongjo Choi; Seonyeong Min; Taeksun Song; Laura E Via; Lisa C Goldfeder; Eunhwa Kang; Boyoung Jin; Hyeeun Park; Hyunkyung Kwak; Hyunchul Kim; Han-Seung Jeon; Ina Jeong; Joon Sung Joh; Ray Y Chen; Kenneth N Olivier; Pamela A Shaw; Dean Follmann; Sun Dae Song; Jong-Koo Lee; Dukhyoung Lee; Cheon Tae Kim; Veronique Dartois; Seung-Kyu Park; Sang-Nae Cho; Clifton E Barry
Journal:  N Engl J Med       Date:  2012-10-18       Impact factor: 91.245

10.  Genome sequencing of linezolid-resistant Streptococcus pneumoniae mutants reveals novel mechanisms of resistance.

Authors:  Jie Feng; Andréanne Lupien; Hélène Gingras; Jessica Wasserscheid; Ken Dewar; Danielle Légaré; Marc Ouellette
Journal:  Genome Res       Date:  2009-04-06       Impact factor: 9.043
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.